NASDAQ : CCRN
Cross Country Healthcare, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 13.25 USD (At close: Jul 20, 2026) · Market cap 428.06M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 428.06M |
| Enterprise Value | 324.52M |
Dates
| Measure | Value |
|---|
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 32.31M |
| Shares Outstanding | 32.31M |
| Shares Change (YoY) | -2.10% |
| Shares Change (QoQ) | -2.67% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 89.41% |
| Float | 31.99M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 72.92 |
| PS Ratio | 0.43 |
| Forward PS | 0.43 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 2.06 |
| P/FCF Ratio | 10.81 |
| P/OCF Ratio | 9.04 |
| PEG Ratio | 7.29 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.32 |
| EV / EBITDA | 22.99 |
| EV / EBIT | n/a |
| EV / FCF | 8.19 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.29 |
| Quick Ratio | 3.20 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.05 |
| Interest Coverage | -0.35 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -26.98% |
| Return on Assets (ROA) | -0.09% |
| Return on Invested Capital (ROIC) | -0.37% |
| Return on Capital Employed (ROCE) | -0.22% |
| Weighted Average Cost of Capital (WACC) | 7.09% |
| Revenue Per Employee | $126,989 |
| Profits Per Employee | -$12,500 |
| Employee Count | 7,890 |
| Asset Turnover | 1.95 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 12.28M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +3.68% |
| 50-Day Moving Average | 13.16 |
| 200-Day Moving Average | 10.76 |
| Relative Strength Index (RSI) | 75.26 |
| Average Volume (20 Days) | 706,252 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 871,295 |
| Short Previous Month | 813,540 |
| Short % of Shares Out | 2.70% |
| Short % of Float | 2.72% |
| Short Ratio (days to cover) | 1.61 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.00B |
| Gross Profit | 202.50M |
| Operating Income | -778,000 |
| Pretax Income | -86.35M |
| Net Income | -98.63M |
| EBITDA | 14.11M |
| EBIT | -778,000 |
| Loss Per Share | -$3.07 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 105.58M |
| Total Debt | 2.04M |
| Net Cash | 103.54M |
| Net Cash Per Share | $3.20 |
| Equity (Book Value) | 312.81M |
| Book Value Per Share | 10.01 |
| Working Capital | 207.73M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 47.34M |
| Capital Expenditures | -7.73M |
| Depreciation & Amortization | 14.89M |
| Net Borrowing | n/a |
| Free Cash Flow | 39.60M |
| FCF Per Share | $1.23 |
Margins
| Measure | Value |
|---|
| Gross Margin | 20.21% |
| Operating Margin | -0.08% |
| Pretax Margin | -8.62% |
| Profit Margin | -9.84% |
| EBITDA Margin | 1.41% |
| EBIT Margin | -0.08% |
| FCF Margin | 3.95% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.10% |
| Shareholder Yield | 2.10% |
| Earnings Yield | -23.04% |
| FCF Yield | 9.25% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.60 |
| Price Target Difference | -4.91% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 0.64% |
| EPS Growth Forecast (3Y) | 164.48% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.8 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |